Free Trial
OTCMKTS:BIEI

Premier Biomedical (BIEI) Stock Price, News & Analysis

Premier Biomedical logo
$0.0006 0.00 (0.00%)
As of 01:46 PM Eastern

About Premier Biomedical Stock (OTCMKTS:BIEI)

Key Stats

Today's Range
$0.0006
$0.0007
50-Day Range
N/A
52-Week Range
$0.0003
$0.0021
Volume
1.84 million shs
Average Volume
6.27 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Premier Biomedical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

BIEI MarketRank™: 

Premier Biomedical scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Premier Biomedical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Premier Biomedical is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Premier Biomedical is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Premier Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Premier Biomedical has recently increased by 350.27%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Premier Biomedical does not currently pay a dividend.

  • Dividend Growth

    Premier Biomedical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Premier Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Premier Biomedical has recently increased by 350.27%, indicating that investor sentiment is decreasing significantly.
  • MarketBeat Follows

    1 people have added Premier Biomedical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Premier Biomedical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.78% of the stock of Premier Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Premier Biomedical's insider trading history.
Receive BIEI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter.

BIEI Stock News Headlines

Premier Graphene Showcases Hemp Graphene for Military Use
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
See More Headlines

BIEI Stock Analysis - Frequently Asked Questions

Premier Biomedical's stock was trading at $0.0007 at the beginning of the year. Since then, BIEI shares have decreased by 14.3% and is now trading at $0.0006.
View the best growth stocks for 2025 here
.

Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Premier Biomedical investors own include Allena Pharmaceuticals (ALNA), Inovio Pharmaceuticals (INO), Co-Diagnostics (CODX), CytoDyn (CYDY), Vaxart (VXRT), Arcturus Therapeutics (ARCT) and Actinium Pharmaceuticals (ATNM).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:BIEI
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:BIEI) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners